OC METRO CALENDAR

  • October 2014
    SuMoTuWeThFrSa
    2829301234
    567891011
    12131415161718
    19202122232425
    2627282930311
    2345678
Add an event

MEDICAL TECHNOLOGY
Untitled Page Published: March 24, 2009



Masimo's hemoglobin monitor continued ...

"Masimo SpHb is an impressive new tool that helps us to more safely guide patients in surgery through to recovery, says Ronald Miller, M.D., chief of Anesthesia and chairman of the Anesthesia and Perioperative Care at UC San Francisco. “With it, not only can we spot hemoglobin changes as they occur, but we can see where they are heading. This ability to identify an upward or downward hemoglobin trend on a second-by-second basis as it occurs has been of tremendous value."

"SpHb's success during the limited market release phase at hospitals around the world illustrates its expected significant impact on clinical practice and patient care,” says Joe Kiani, Founder and CEO of Masimo. “As we expected, our limited market release program provided us with the opportunity to enhance the robustness in low perfusion situations and broaden the cross section of individuals on which the technology performs …”
SpHb has received regulatory clearance in the U.S., Canada, Europe and Australia, and is now available for sale in most of the countries in the world.

PAGE ONE

Related headlines
“OC METRO Minute,” March 24: DaVinci Biosciences – adult stem cell trial/spinal cord injury
Irvine’s Cortex Pharmaceuticals restructures, downsizes
“OC METRO Minute,” March 13: UCI’s geriatric program receives funding from Donald W. Reynolds Foundation
Studies show Irvine’s Cortex therapy slows memory loss
Irvine’s Spectrum Pharmaceuticals acquires RIT Oncology
San Clemente's STEMTech to Obama: What about adult stem cells?